Peter H Shaw MD
  • Peter H. Shaw, MD

    Dr. Shaw is the head of the Adolescent and Young Adult (AYA) Oncology Program at Children's Hospital of Pittsburgh of UPMC. He is an expert in AYA acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML), and their treatment.

Peter H. Shaw, MD

Dr. Shaw is the head of the Adolescent and Young Adult (AYA) Oncology Program at Children's Hospital of Pittsburgh of UPMC. He is an expert in AYA acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML), and their treatment.

Profile:

University of Pittsburgh Physicians
Pediatric Hematology/Oncology

Office Address(es):
Children's Hospital of Pittsburgh of UPMC
One Children's Hospital Drive 4401 Penn Avenue, 9th Floor
Pittsburgh, PA 15224
Phone: (412) 692-5055

Specialty:
Pediatrics

Sub Specialty:
Pediatric Hematology-Oncology
Pediatric Medical Oncology

Board Certifications:
Pediatric Hematology-Oncology

Education:
Albert Einstein College of Medicine, Bronx, NY

Residency:
Montefiore Medical Center The University Hospital for the Albert Einstein College of Medicine, Bronx, NY

Fellowships:
Children's Memorial Hospital - Chicago, Chicago, IL

Hospital Affiliation(s):
Children's Hospital of Pittsburgh of UPMC
UPMC Shadyside

Language (in addition to English): Spanish

Medical School:
1994 Albert Einstein College of Medicine, Bronx, NY

Residency:
1997 Montefiore Medical Center, Bronx, NY

Fellowship:
2000 Children's Memorial Hospital, Chicago, IL

Memberships:
American Society of Clinical Oncology
American Society of Pediatric Hematology/Oncology
American Society of Hematology
American Academy of Pediatrics

Board Certifications:
American Board of Pediatrics - Hematology/Oncology

Awards:

  • Oustanding Achievement in Patient Care (Top 25 Physician, Overall Quality of Care) Children's Hospital of Pittsburgh, 2007
  • Oustanding Achievement in Patient Care (Top 25 Physician, Overall Quality of Care) Children's Hospital of Pittsburgh, 2006
  • Oustanding Achievement in Patient Care (Top 25 Physician, Overall Quality of Care) Children's Hospital of Pittsburgh, 2005
  • Oustanding Achievement in Patient Care (Top 10 Physician, Overall Quality of Care) Children's Hospital of Pittsburgh, 2003
  • 1st Prize, Hemophilia Research Society Research Competition at International Society of Thrombosis and Hemostasis Annual Meeting, Birmingham, UK, 2003
  • American Society of Pediatric Hematology/Oncology 2002 Young Investigator's Award
  • Children's Hospital of Pittsburgh Research Advisory Committee Faculty Startup Grant 2000
  • Children's Oncology Group Young Investigator Grant 2000

Publications:

  • Downs-Canner S, Shaw PH. A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers. J Pediatr Hematol Oncol. 2009 Dec;31(12):927-9.
  • Shaw PH, Reynolds S, Gunawardena S, Krishnamurti L, Ritchey AK.   The prevalence of bleeding disorders among healthy pediatric patients with abnormal pre-procedural coagulation studies.  J Pediatr Hematol Oncol, 2008:30(2):135-141.
  • Shaw PH, Ritchey AK.  Different Rates of Clinical Trial Enrollment between Adolescents and Young Adults Aged 15 to 21 Years-Old and Children Under 15 Years-Old with Cancer at a Children’s Hospital.  J Pediatr Hematol Oncol, 2007:29(12):811-814.
  • Shaw PH, Gilligan D, Wang X, Thall PJ, Corey SJ: Ex vivo explansion of megakaryocyte precursors from umbilical cord blood CD34+ cells in a closed liquid culture system. Biol Blood Marrow Transplant, 2003:9(3):151-156.
  • Shaw PH, Olszewski M, Kletzel M: Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media. Jnl of Hematotherapy and Stem Cell Research, 10:391-403, 2001.

Research Interests:
Adolescent and Young Adult Oncology (AYA) Program
Dr. Shaw has established one of the few Adolescent and Young Adult Oncology (AYA) Oncology Programs in the United States at Children's Hospital of Pittsburgh of UPMC.  Through this program he studies barriers to providing the best care to this unique population of cancer patients.

Fertility Preservation in Oncology and Bone Marrow Transplant Patients
Dr. Shaw works closely with the Center for Fertility and Reproductive Endocrinology at Magee Women’s Hospital to study cutting-edge approaches to preserve fertility in patients whose curative therapy will adversely affect their ability to reproduce. He is the principal investigator for an IRB-approved protocol to freeze ovarian tissue and co-investigator for an IRB-approved protocol to freeze testicular tissue prior to chemotherapy and/or radiation for appropriate patients.

IRB-approved Bleeding Registry
Dr. Shaw is also interested in the prevalence of true bleeding disorders among children referred for bleeding. An IRB-approved bleeding registry has been established to study this question.